Abstract
Ropivacaine has been extensively investigated for use in neuraxial anesthesia/analgesia in cesarean section and labor analgesia. It has an excellent safety profile for both mother and neonate. However, its weak motor blockade has not been shown to result in decreased instrumental delivery rate when used for labor analgesia. Less cardiotoxicity of ropivacaine is most useful when used for epidural anesthesia for cesarean section.